Evidence map›Paper›PMID 39861251›Full record

ArticlePolymers2025

Decoding the Biobased Blueprint: Key Players and Evolutionary Trends in Materials Innovation.

Silvia Rita Sedita, Eleonora Di Maria, Leonardo Mazzoni, Negalegn Alemu Bekele

Abstract read
In one paragraph

Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Silvia Rita SeditaDepartment of Economics and Management, University of Padova, 35123 Padova, Italy.ORCID 0000-0002-4589-6934
Eleonora Di MariaDepartment of Economics and Management, University of Padova, 35123 Padova, Italy.ORCID 0000-0003-4595-2155
Leonardo MazzoniEuropean University Institute, Robert Schuman Centre, Centre for a Digital Society, 50133 Florence, Italy.ORCID 0000-0002-0231-9248
Negalegn Alemu BekeleDepartment of Mechanical Engineering, Debre Markos University, Debre Markos 251, Ethiopia.

Funding

European Sustainable BIObased nanoMAterials Community (BIOMAC) Grant Agreement number: 952941
6 · The paper itself

Abstract

In the rapidly evolving biobased materials innovation landscape, our research identifies key players and explores the evolutionary perspective of biobased innovation, offering insights into promising research areas to be further developed by biobased material scientists in search of exploiting their knowledge in novel applications. Despite the crucial role of these materials in promoting sustainable production and consumption models, systematic studies on the current innovation terrain are lacking, leaving gaps in understanding key players, emerging technologies, and market trends. To address this void, we focused on examining patents related to biobased monomers and polymers, aiming to describe the innovation strategies and business dynamics of leading assignees. Embedded within the European Sustainable BIO-based nanoMAterials Community (BIOMAC) project, a Horizon 2020 initiative, our research leverages this unique framework dedicated to advancing the innovation landscape, specifically emphasizing the market readiness of biobased materials. We implemented a multi-stage strategy, prioritizing validated keyword queries to ensure the superior quality and reliability of the collected data. To understand primary contributors within these landscapes, we conducted an in-depth analysis of innovation strategies employed by leading companies. Findings from the ORBIT platform highlighted a remarkable increase in patent publications in the past decade, with China standing out as a key hub of innovation, signaling a strong focus on the development of these materials. Our research explores technological advancements in biobased materials to identify specific areas with potential for further development. By analyzing innovation trends in five key industries, we pinpoint opportunities for innovative solutions to be commercially exploited while ensuring compliance with intellectual property rights within a freedom-to-operate framework.

Indexed as

biobased materialsBIOMACcommercializationexploitationfreedom-to-operateinnovation landscapepatent analysistechnological leadership

Identifiers

PMID39861251
PMCPMC11768121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.